Drug
Who makes doxylamine succinate and pyridoxine hydrochloride?
4 companies list doxylamine succinate and pyridoxine hydrochloride as a human prescription drug, including under the names BONJESTA, DICLEGIS. Forms: tablet, delayed release; tablet, extended release. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing doxylamine succinate and pyridoxine hydrochloride
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Duchesnay Inc.Canada | tablet, delayed release; tablet, extended release | NDANDA021876, NDA209661 | 2 | 1 |
| Actavis LLCUnited States | tablet, delayed release | ANDAANDA205811 | 1 | 1 |
| Bionpharma Inc.India | tablet, delayed release | ANDAANDA217000 | 1 | 1 |
| Analog Pharma | tablet, delayed release | NDA AUTHORIZED GENERICNDA021876 | 1 | 0 |
Enquiry
Common questions
- Who makes doxylamine succinate and pyridoxine hydrochloride?
- 4 companies list doxylamine succinate and pyridoxine hydrochloride as a human prescription drug in the openFDA NDC Directory, led by Duchesnay Inc., Actavis LLC, Bionpharma Inc., Analog Pharma. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic BONJESTA?
- 2 companies list doxylamine succinate and pyridoxine hydrochloride under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.